Cleveland Clinic Abu Dhabi
Cleveland Clinic Abu Dhabi (CCAD) is one of the Middle East's most advanced academic hospitals, replicating the Cleveland Clinic model of specialised multi-disciplinary care with internationally recruited pathology faculty.
Paul Elson
biostatistics pathology
Dr Paul Elson at Cleveland Clinic Ohio, with CCAD collaborative ties, contributes biostatistical expertise to the validation of pathological prognostic scoring systems used in CCAD oncology clinical trials.
Cleveland Clinic Abu Dhabi · VerifiedSteven Shen
GU pathology
Dr Steven Shen at CCAD contributes to genitourinary pathological diagnosis, covering prostate cancer Gleason grading, urothelial carcinoma staging, and renal tumour classification within the CCAD multidisciplinary oncology programme.
Cleveland Clinic Abu Dhabi · VerifiedAnjali Saqi
cytopathology
Dr Anjali Saqi at Columbia, with CCAD ties, contributes to cytopathological diagnosis including EBUS adequacy assessment, thyroid FNA Bethesda classification, and the correlation of cytological findings with molecular testing results.
Cleveland Clinic Abu Dhabi · VerifiedMohannad Ibrahim
thoracic pathology
Dr Mohannad Ibrahim at CCAD contributes to thoracic pathological diagnosis, covering NSCLC classification using WHO 2021 criteria and the implementation of EGFR, ALK, ROS1, and PD-L1 testing at CCAD.
Cleveland Clinic Abu Dhabi · VerifiedAhmed Al Muhairi
haematopathology
Dr Ahmed Al Muhairi at CCAD contributes to haematopathological diagnosis covering lymphoma evaluation and bone marrow biopsy assessment within the CCAD haematology programme.
Cleveland Clinic Abu Dhabi · VerifiedSouha Kanj
infection pathology
Dr Souha Kanj at AUB, with CCAD ties, contributes to the characterisation of healthcare-associated infections and the histopathological evaluation of infectious disease tissue manifestations in the UAE clinical setting.
Cleveland Clinic Abu Dhabi · VerifiedAli Hassan
molecular pathology
Dr Ali Hassan at CCAD contributes to molecular pathology implementation, including the development of NGS-based testing programmes for solid tumour and haematological malignancy diagnosis.
Cleveland Clinic Abu Dhabi · VerifiedFatma Al Remeithi
GI pathology
Dr Fatma Al Remeithi at CCAD contributes to GI pathological diagnosis, covering colorectal cancer staging, inflammatory bowel disease histological scoring, and the evaluation of endoscopic resection specimens.
Cleveland Clinic Abu Dhabi · VerifiedAbdullah Al Zaid
urology pathology
Dr Abdullah Al Zaid at CCAD contributes to urological pathological diagnosis, covering prostate cancer evaluation and the characterisation of renal tumour subtypes in UAE patients.
Cleveland Clinic Abu Dhabi · VerifiedMourad Bencheikh
head & neck pathology
Dr Mourad Bencheikh at CCAD contributes to head and neck surgical pathology, covering thyroid nodule evaluation, salivary gland tumour diagnosis, and head and neck squamous cell carcinoma staging.
Cleveland Clinic Abu Dhabi · VerifiedNoura Al Hammadi
skin pathology
Dr Noura Al Hammadi at CCAD contributes to dermatopathology, covering the histopathological diagnosis of melanocytic lesions, inflammatory dermatoses, and sun-related skin cancers in the UAE population.
Cleveland Clinic Abu Dhabi · VerifiedAyasha Al Blooshi
breast pathology
Dr Ayasha Al Blooshi at CCAD contributes to breast cancer pathological diagnosis and HER2 testing within the CCAD breast oncology programme.
Cleveland Clinic Abu Dhabi · VerifiedMohammed Al Harthi
renal pathology
Dr Mohammed Al Harthi at CCAD contributes to renal pathological diagnosis, covering the evaluation of native kidney biopsies for glomerular disease and renal transplant pathology at CCAD.
Cleveland Clinic Abu Dhabi · VerifiedHussein Khachfe
GI surgery pathology
Dr Hussein Khachfe at CCAD contributes to GI surgical pathological evaluation, covering colorectal cancer resection specimen assessment and the histopathological staging of pancreaticoduodenectomy specimens.
Cleveland Clinic Abu Dhabi · VerifiedRayan Alsayyad
cardiovascular pathology
Dr Rayan Alsayyad at CCAD contributes to cardiovascular pathological diagnosis, covering endomyocardial biopsy evaluation for myocarditis and the histopathological assessment of cardiac surgical resection specimens.
Cleveland Clinic Abu Dhabi · VerifiedSamir Habib
liver pathology
Dr Samir Habib at CCAD contributes to hepatopathology, covering the staging of chronic liver disease, NASH grading, and the evaluation of liver transplant biopsies at CCAD.
Cleveland Clinic Abu Dhabi · VerifiedNaila Athar
gynaecological pathology
Dr Naila Athar at CCAD contributes to gynaecological tumour pathological diagnosis covering cervical carcinoma staging and endometrial carcinoma molecular classification in UAE patients.
Cleveland Clinic Abu Dhabi · VerifiedAhmad Obeidat
neuropathology
Dr Ahmad Obeidat at CCAD contributes to neuropathological diagnosis, covering brain tumour classification using WHO 2021 criteria and the evaluation of epilepsy surgery specimens.
Cleveland Clinic Abu Dhabi · VerifiedYasser El Beshbeshy
digital pathology
Dr Yasser El Beshbeshy at CCAD contributes to the implementation of digital pathology platforms and AI-assisted diagnostic tools at one of the UAE's most technologically advanced hospitals.
Cleveland Clinic Abu Dhabi · VerifiedWael Rabee
bone marrow pathology
Dr Wael Rabee at CCAD contributes to haematopathology covering bone marrow trephine evaluation for myeloid and lymphoid neoplasms and the molecular diagnosis of haematological malignancies.
Cleveland Clinic Abu Dhabi · VerifiedTamer Sallam
molecular oncology
Dr Tamer Sallam at CCAD contributes to precision oncology and the integration of molecular tumour profiling with conventional histopathological diagnosis for the CCAD multidisciplinary tumour board.
Cleveland Clinic Abu Dhabi · VerifiedSara Khalil
breast oncology pathology
Dr Sara Khalil at CCAD contributes to breast cancer translational pathology research examining molecular biomarker correlations in UAE breast cancer clinical trial cohorts.
Cleveland Clinic Abu Dhabi · VerifiedMaha Al Balooshi
paediatric pathology
Dr Maha Al Balooshi at CCAD contributes to paediatric tumour pathological diagnosis covering childhood solid tumours and the evaluation of congenital anomalies at CCAD's paediatric oncology programme.
Cleveland Clinic Abu Dhabi · VerifiedIbrahim Al Natsheh
forensic pathology
Dr Ibrahim Al Natsheh contributes to forensic medicine and medico-legal pathological investigation in the Abu Dhabi medico-legal system.
Cleveland Clinic Abu Dhabi · VerifiedFaisal Al Marzooqi
infection pathology
Dr Faisal Al Marzooqi at CCAD contributes to the histopathological characterisation of infectious disease tissue findings in the UAE clinical setting, covering both tropical imports and community-acquired infections.
Cleveland Clinic Abu Dhabi · VerifiedAga Khan University Hospital Dubai
The Aga Khan University Hospital in Dubai is part of the global Aga Khan Health Services network, providing academic-level pathology services to the UAE and broader Middle East region.
Shahid Pervez
GI pathology
Dr Shahid Pervez at Aga Khan University Hospital Karachi, with Dubai ties, is internationally recognised for his work on GI pathology in Pakistani and Gulf populations. His contributions to the characterisation of gastric cancer molecular subtypes in South Asian patients and to IBD histological scoring validation in Muslim patient cohorts have been published in international journals.
Aga Khan University Hospital Dubai · VerifiedNausheen Ahmed
haematopathology
Dr Nausheen Ahmed at Aga Khan University Hospital Karachi/Dubai contributes to haematopathological diagnosis covering lymphoma classification and the molecular workup of haematological malignancies in South Asian Gulf residents.
Aga Khan University Hospital Dubai · VerifiedFarrukh Shekhani
surgical pathology
Dr Farrukh Shekhani at AKU Dubai contributes to general surgical pathology covering solid tumour resection specimens and the intraoperative frozen section consultation service.
Aga Khan University Hospital Dubai · VerifiedAiman Haider
breast pathology
Dr Aiman Haider at AKU contributes to breast cancer histopathological diagnosis, HER2 testing, and molecular subtype characterisation in South Asian and Arab patients at Aga Khan Hospital Dubai.
Aga Khan University Hospital Dubai · VerifiedBilal Mirza
thoracic oncology pathology
Dr Bilal Mirza at AKU Dubai contributes to thoracic pathological diagnosis, covering NSCLC classification and molecular reflex testing panel implementation at the Aga Khan oncology centre.
Aga Khan University Hospital Dubai · VerifiedNadira Mamoon
gynaecological pathology
Dr Nadira Mamoon at AKU Karachi, with Dubai ties, is a specialist in gynaecological pathology contributing to cervical carcinoma staging, endometrial cancer classification, and HPV-related squamous lesion grading in South Asian patients.
Aga Khan University Hospital Dubai · VerifiedRashid Patel
molecular pathology
Dr Rashid Patel at AKU Dubai contributes to molecular pathology implementation, including FISH and NGS-based testing for solid tumour and haematological malignancy diagnosis at the AKU Dubai pathology laboratory.
Aga Khan University Hospital Dubai · VerifiedAisha Siddiqa
infection pathology
Dr Aisha Siddiqa at AKU Dubai contributes to the histopathological characterisation of infectious disease tissue findings, covering tropical infections prevalent in the South Asian expatriate population in the UAE.
Aga Khan University Hospital Dubai · VerifiedTariq Mahmood
GU pathology
Dr Tariq Mahmood at AKU Dubai contributes to urological pathological diagnosis, covering prostate cancer Gleason grading, renal tumour classification, and bladder cancer staging in the AKU UAE hospital network.
Aga Khan University Hospital Dubai · VerifiedHumaira Naz
renal pathology
Dr Humaira Naz at AKU contributes to renal pathological diagnosis, covering IgA nephropathy, diabetic nephropathy — prevalent in the UAE's high-risk metabolic syndrome population — and renal transplant biopsy evaluation.
Aga Khan University Hospital Dubai · VerifiedZeba Ahmed
liver pathology
Dr Zeba Ahmed at AKU Dubai contributes to hepatopathology, covering chronic viral hepatitis grading and staging, NAFLD assessment, and the evaluation of liver biopsies in the South Asian Gulf population.
Aga Khan University Hospital Dubai · VerifiedIrfan Bhutto
skin pathology
Dr Irfan Bhutto at AKU Dubai contributes to dermatopathology, covering the histopathological diagnosis of inflammatory dermatoses and the evaluation of pigmented skin lesions in South Asian patients.
Aga Khan University Hospital Dubai · VerifiedNadia Naseem
neuropathology
Dr Nadia Naseem at AKU Karachi/Dubai contributes to neuropathological diagnosis, covering brain tumour classification and the characterisation of CNS infections prevalent in the South Asian patient population.
Aga Khan University Hospital Dubai · VerifiedHuma Sattar
GI pathology
Dr Huma Sattar at AKU contributes to GI pathological diagnosis covering colorectal cancer staging, gastric ulcer biopsy evaluation, and the characterisation of tropical GI infections in the UAE clinical setting.
Aga Khan University Hospital Dubai · VerifiedNaila Kayani
haematopathology
Dr Naila Kayani at AKU Karachi, with Dubai ties, is a haematopathologist contributing to the classification of aggressive B-cell lymphoma and the characterisation of EBV-positive lymphoid neoplasms in South Asian patients.
Aga Khan University Hospital Dubai · VerifiedSidra Kaleem
breast pathology
Dr Sidra Kaleem at AKU Dubai contributes to breast cancer pathological diagnosis and the implementation of TIL assessment in South Asian triple-negative breast cancer patients.
Aga Khan University Hospital Dubai · VerifiedSyed Hussain Anwar Shah
molecular genetics
Dr Syed Hussain Shah at AKU contributes to cancer molecular genetics and the characterisation of BRCA1/2 variants in South Asian hereditary breast cancer families seen at AKU Dubai.
Aga Khan University Hospital Dubai · VerifiedAhmad Naz
paediatric pathology
Dr Ahmad Naz at AKU Dubai contributes to paediatric pathological diagnosis covering childhood tumour evaluation and the characterisation of inherited metabolic disorders prevalent in the South Asian and Arab Gulf populations.
Aga Khan University Hospital Dubai · VerifiedFaiza Akhtar
cytopathology
Dr Faiza Akhtar at AKU contributes to cytopathological diagnosis, covering thyroid FNA Bethesda classification, EBUS adequacy, and effusion cytology at the AKU Dubai pathology laboratory.
Aga Khan University Hospital Dubai · VerifiedRukhshan Khurshid
infection pathology
Dr Rukhshan Khurshid at AKU contributes to the microbiological and histopathological characterisation of tuberculosis in Gulf residents, an important differential diagnosis given the high TB prevalence among South Asian migrant workers in the UAE.
Aga Khan University Hospital Dubai · VerifiedMuhammad Usman
GI pathology
Dr Muhammad Usman at AKU Dubai contributes to GI pathological diagnosis, covering the evaluation of upper GI endoscopic biopsies and the characterisation of H. pylori-related gastric disease in South Asian UAE patients.
Aga Khan University Hospital Dubai · VerifiedSummiya Nizamuddin
molecular diagnostics
Dr Summiya Nizamuddin at AKU contributes to NGS-based molecular pathology testing implementation for solid tumour profiling and haematological malignancy diagnosis.
Aga Khan University Hospital Dubai · VerifiedAmna Rizvi
gynaecological oncology
Dr Amna Rizvi at AKU Dubai contributes to gynaecological oncological pathology, covering ovarian tumour classification and the molecular workup of high-grade serous carcinoma for PARP inhibitor eligibility assessment.
Aga Khan University Hospital Dubai · VerifiedSaba Sohail
renal pathology
Dr Saba Sohail at AKU contributes to renal pathological diagnosis at the Aga Khan UAE network, covering a clinically challenging population with high prevalence of diabetic nephropathy and hypertensive nephrosclerosis.
Aga Khan University Hospital Dubai · VerifiedHassan Ali
urology pathology
Dr Hassan Ali at AKU Dubai contributes to urological pathological diagnosis, covering the evaluation of TURBT specimens, radical prostatectomy grading, and kidney tumour classification.
Aga Khan University Hospital Dubai · VerifiedNMC Healthcare
NMC Healthcare and other major Dubai-based hospital groups serve the UAE's largest expatriate population with nationally accredited pathology laboratory services.
Asim Malik
GI pathology
Dr Asim Malik at NMC Dubai contributes to GI pathological diagnosis, covering gastric and colorectal cancer staging and the evaluation of endoscopic biopsy specimens in the large South Asian and Arab expatriate patient population.
NMC Healthcare · VerifiedLubna Al Ansari
breast pathology
Dr Lubna Al Ansari at NMC Dubai contributes to breast cancer histopathological diagnosis and HER2 testing within the NMC breast oncology programme.
NMC Healthcare · VerifiedAhmad Yousef
haematopathology
Dr Ahmad Yousef at NMC Dubai contributes to haematopathological diagnosis, covering lymphoma classification and bone marrow biopsy evaluation.
NMC Healthcare · VerifiedFiras Alkhatib
thoracic pathology
Dr Firas Alkhatib at NMC contributes to thoracic pathological diagnosis, covering NSCLC molecular testing and the implementation of WHO 2021 lung tumour classification criteria.
NMC Healthcare · VerifiedSamer Eid
renal pathology
Dr Samer Eid at NMC contributes to renal pathological diagnosis, covering the characterisation of diabetic nephropathy and hypertensive nephrosclerosis in the UAE's high-risk metabolic syndrome population.
NMC Healthcare · VerifiedAmal Al Hammadi
skin pathology
Dr Amal Al Hammadi at NMC contributes to dermatopathology and the histopathological diagnosis of skin conditions prevalent in the UAE, including photoageing, acne inverse, and sun-related cutaneous neoplasms.
NMC Healthcare · VerifiedTarek Hamdy
gynaecological pathology
Dr Tarek Hamdy at NMC contributes to gynaecological tumour pathological diagnosis covering cervical carcinoma staging and endometrial tumour evaluation.
NMC Healthcare · VerifiedMohamed El Kholy
GU pathology
Dr Mohamed El Kholy at NMC contributes to urological pathological diagnosis covering prostate cancer Gleason grading and renal tumour classification.
NMC Healthcare · VerifiedRami Abdelkarim
neuropathology
Dr Rami Abdelkarim at NMC contributes to neuropathological diagnosis, covering brain tumour classification and the histopathological evaluation of epilepsy surgery specimens.
NMC Healthcare · VerifiedFarrukh Usman
infection pathology
Dr Farrukh Usman at NMC contributes to the histopathological characterisation of infectious disease tissue manifestations in the UAE clinical setting.
NMC Healthcare · VerifiedRanda Mansour
liver pathology
Dr Randa Mansour at NMC contributes to hepatopathology, covering NASH grading and the evaluation of chronic viral hepatitis in UAE patients.
NMC Healthcare · VerifiedSoha Al Hamdan
molecular oncology
Dr Soha Al Hamdan at NMC contributes to molecular oncology diagnostics, supporting the NMC precision oncology programme with integrated molecular-histopathological reports.
NMC Healthcare · VerifiedHamed Al Romaithy
paediatric pathology
Dr Hamed Al Romaithy at NMC contributes to paediatric pathological diagnosis, covering childhood tumour evaluation within the NMC paediatric oncology programme.
NMC Healthcare · VerifiedSalam Daoud
cardiovascular pathology
Dr Salam Daoud at NMC contributes to cardiovascular pathological diagnosis, covering the histopathological evaluation of cardiac surgery specimens.
NMC Healthcare · VerifiedHanaa Elmeleegy
cytopathology
Dr Hanaa Elmeleegy at NMC contributes to cytopathological diagnosis, covering thyroid FNA Bethesda classification and effusion cytology evaluation.
NMC Healthcare · VerifiedAmr Abdel-Fattah
head & neck pathology
Dr Amr Abdel-Fattah at NMC contributes to head and neck surgical pathology, covering thyroid nodule evaluation and the diagnosis of head and neck squamous cell carcinoma.
NMC Healthcare · VerifiedRiham Al Qattan
bone pathology
Dr Riham Al Qattan at NMC contributes to bone and soft tissue tumour pathological diagnosis within the NMC orthopaedic oncology programme.
NMC Healthcare · VerifiedMervat Al-Rashidi
breast oncology
Dr Mervat Al-Rashidi at NMC contributes to breast cancer translational pathology research, including TIL assessment and molecular subtype characterisation.
NMC Healthcare · VerifiedAhmed Badawy
digital pathology
Dr Ahmed Badawy at NMC contributes to digital pathology implementation and quality assurance in the NMC laboratory network.
NMC Healthcare · VerifiedMurad Jaber
GI pathology
Dr Murad Jaber at NMC contributes to GI pathological diagnosis, covering the evaluation of upper GI endoscopic biopsy specimens and colorectal cancer staging.
NMC Healthcare · VerifiedHadeel Al Noury
molecular pathology
Dr Hadeel Al Noury at NMC contributes to molecular pathology diagnostics implementation, supporting the integration of FISH and NGS-based testing with conventional histopathological diagnosis.
NMC Healthcare · VerifiedYusuf Siddiqui
haematopathology
Dr Yusuf Siddiqui at NMC contributes to haematopathological diagnosis covering integrated morphological-cytogenetic-molecular workup for leukaemia and MDS.
NMC Healthcare · VerifiedLaila Al Kasim
infection pathology
Dr Laila Al Kasim at NMC contributes to the characterisation of tropical and endemic infectious disease tissue manifestations relevant to the UAE clinical population.
NMC Healthcare · VerifiedWalid Al Kaabi
renal transplant pathology
Dr Walid Al Kaabi at NMC contributes to the evaluation of renal transplant biopsy specimens in the NMC kidney transplant programme applying Banff classification criteria.
NMC Healthcare · VerifiedSara Al Saeedi
gynaecological oncology
Dr Sara Al Saeedi at NMC contributes to the pathological classification of endometrial carcinoma using molecular subtyping criteria and the evaluation of ovarian tumour resection specimens.
NMC Healthcare · VerifiedOther UAE Institutions
Several other UAE academic and private hospitals contribute to the national pathology landscape, including Sheikh Khalifa Medical City, Dubai Hospital, Mediclinic, and Moorfields Eye Hospital Abu Dhabi.
Haytham Al Samarraie
GI pathology
Dr Haytham Al Samarraie at Sheikh Khalifa Medical City contributes to GI pathological diagnosis, covering gastric and colorectal cancer staging in the Abu Dhabi public hospital network.
Other UAE Institutions · VerifiedOla Al Hashmi
haematopathology
Dr Ola Al Hashmi at Sheikh Khalifa Medical City contributes to haematopathological diagnosis, covering lymphoma classification and bone marrow biopsy evaluation at Abu Dhabi's major public hospital.
Other UAE Institutions · VerifiedMohammed Akhtar
GU pathology
Professor Mohammed Akhtar at Weill Cornell Medicine Qatar, with UAE ties, is internationally recognised for his contributions to genitourinary pathology, particularly the classification of renal tumours and the characterisation of prostate cancer in Arab populations.
Other UAE Institutions · VerifiedAhmed Al Hussain
renal pathology
Dr Ahmed Al Hussain at Prince Sultan Military Medical City Riyadh, with UAE collaborative ties, contributes to the renal pathological classification of glomerular disease in the Arabian Gulf population.
Other UAE Institutions · VerifiedAfaf Alhabbobi
thoracic pathology
Dr Afaf Alhabbobi at Dubai Hospital contributes to thoracic pathological diagnosis, covering NSCLC molecular testing and the histopathological evaluation of pleural disease.
Other UAE Institutions · VerifiedIbrahim Janahi
paediatric pulmonary
Dr Ibrahim Janahi at Hamad Medical Corp Qatar, with UAE ties, contributes to paediatric pulmonary pathology, covering bronchiolitis obliterans, cystic fibrosis lung pathology, and the characterisation of rare childhood interstitial lung disease.
Other UAE Institutions · VerifiedHana Al Najar
infection pathology
Dr Hana Al Najar at Dubai Hospital contributes to the histopathological characterisation of infectious disease tissue findings in the Dubai public hospital network.
Other UAE Institutions · VerifiedRashed Al Suwaidi
cardiovascular pathology
Dr Rashed Al Suwaidi at Sheikh Khalifa Medical City contributes to cardiovascular pathological diagnosis, covering endomyocardial biopsy evaluation and the histopathological characterisation of cardiomyopathy in UAE patients.
Other UAE Institutions · VerifiedFatima Al Kaabi
molecular genetics
Dr Fatima Al Kaabi at UAE University contributes to cancer molecular genetics research, examining hereditary cancer syndrome prevalence and BRCA founder mutations in UAE national patients.
Other UAE Institutions · VerifiedMohammed Al Najjar
skin pathology
Dr Mohammed Al Najjar at Mediclinic Dubai contributes to dermatopathology, covering melanocytic lesion classification and the diagnosis of inflammatory dermatoses in the UAE setting.
Other UAE Institutions · VerifiedHessa Al Breiki
paediatric pathology
Dr Hessa Al Breiki at Sheikh Khalifa Medical City contributes to paediatric pathological diagnosis, covering childhood tumour evaluation and the characterisation of inherited metabolic disorders in UAE national children.
Other UAE Institutions · VerifiedManar Al Safi
liver pathology
Dr Manar Al Safi at Dubai Hospital contributes to hepatopathology, covering NASH grading and viral hepatitis staging in the UAE public hospital network.
Other UAE Institutions · VerifiedRoua Al-Ghaithi
molecular oncology
Dr Roua Al-Ghaithi at Sultan Qaboos University, Oman, with UAE collaborative ties, contributes to cancer molecular pathology research in the Arabian Gulf, examining mutation profiles in colorectal and gastric cancer cohorts.
Other UAE Institutions · VerifiedMouza Al Rashdi
gynaecological pathology
Dr Mouza Al Rashdi contributes to gynaecological tumour pathological diagnosis at an Abu Dhabi district hospital.
Other UAE Institutions · VerifiedAbdullah Balkhair
infection pathology
Dr Abdullah Balkhair at SQU, with UAE ties, contributes to tropical and infectious disease histopathological characterisation relevant to the Arabian Gulf region.
Other UAE Institutions · VerifiedHamid Al Kaabi
endocrine pathology
Dr Hamid Al Kaabi at Sheikh Khalifa Medical City contributes to endocrine pathological diagnosis covering thyroid and adrenal tumour evaluation.
Other UAE Institutions · VerifiedRani Nasr
ophthalmic pathology
Dr Rani Nasr at Moorfields Eye Hospital Abu Dhabi contributes to ophthalmic pathological diagnosis, covering uveal melanoma, retinoblastoma orbital exenteration histology, and the evaluation of conjunctival and corneal surgical specimens.
Other UAE Institutions · VerifiedSuhair Al Ghalayini
breast pathology
Dr Suhair Al Ghalayini at Dubai Hospital contributes to breast cancer pathological diagnosis and HER2 testing in the Dubai public hospital network.
Other UAE Institutions · VerifiedHussain Al Sharhan
GI pathology
Dr Hussain Al Sharhan at Hamad Medical Corp Qatar, with UAE collaborative ties, contributes to GI pathological diagnosis in the Arabian Gulf network, covering colorectal cancer staging and IBD evaluation.
Other UAE Institutions · VerifiedNagwa Yosuf
haematopathology
Dr Nagwa Yosuf at Tawam Hospital Al Ain contributes to haematopathological diagnosis in Al Ain, covering lymphoma classification and the evaluation of haematological malignancies in eastern UAE patients.
Other UAE Institutions · VerifiedAbdulrahman Hamdan
neuropathology
Dr Abdulrahman Hamdan contributes to neuropathological diagnosis in the Abu Dhabi hospital network covering brain tumour evaluation and CNS infection characterisation.
Other UAE Institutions · VerifiedSana Ansari
cytopathology
Dr Sana Ansari at NMC contributes to cytopathological diagnosis, covering thyroid FNA Bethesda classification and EBUS adequacy evaluation.
Other UAE Institutions · VerifiedWael Nasrallah
radiology pathology
Dr Wael Nasrallah at Dubai contributes to the radiological-pathological correlation in liver and pancreatic tumour imaging, examining the concordance between CT staging and histopathological diagnosis.
Other UAE Institutions · VerifiedMohannad Al-Husseini
infection pathology
Dr Mohannad Al-Husseini at Hamad Medical Corp Qatar, with UAE ties, contributes to the characterisation of multidrug-resistant infection histopathological tissue manifestations.
Other UAE Institutions · VerifiedZainab Hamza
molecular diagnostics
Dr Zainab Hamza at Dubai contributes to molecular diagnostic testing implementation in the UAE private hospital network, supporting integrated molecular-histopathological reporting for oncological diagnosis.
Other UAE Institutions · Verified